شیوع سندرم متابولیک بر اساس تعریف جدیدIDF و همخوانی آن با تعاریف ATPIII و WHO در مطالعه قند و لیپید تهران
Authors
Abstract:
In April 2005, the International Diabetes Federation (IDF) has formulated a new worldwide definition of the metabolic syndrome in a global consensus statement built on earlier WHO, the ATPIII definitions. The aim of this study was to estimate the prevalence of this syndrome using the IDF definition among Iranian adults and to compare it with the prevalence estimated using the two other definitions. Methods: The prevalence of the MES was determined according to the three different definitions in 10368 men and women aged≥20 years participated in the cross-sectional phase of the Tehran Lipid and Glucose Study (TLGS). To assess the degree of agreement between different MES definitions, the k test was used. Results: The prevalence of MES (95% confidence interval) was 32.1% (31.2-33.0) by the IDF definition, 33.2% (32.3-34.1) by the ATPIII and 18.4% (17.6-19.2) according to the WHO definition. The sensitivity, specificity and concordance of the IDF definition for detecting MES were 91%, 89% for the ATPIII definitions and 73%, 77% for the WHO definition, respectively. The k statistics for the agreement of the IDF definition was 66.3±0.01 with the ATPIII and 39.5±0 with the WHO definition. Conclusion: In the Iranian population, the IDF definition for MES has a good concordance with the ATP III definition and a low concordance with the WHO definition.
similar resources
شیوع سندرم متابولیک بر اساس تعریف جدیدidf و همخوانی آن با تعاریف atpiii و who در مطالعه قند و لیپید تهران
سندرم متابولیک توسط تعاریف مختلف بیان شده است. اخیرا در آپریل سال 2005، فدراسیون بین المللی دیابت (idf) تعریف جدیدی از سندرم متابولیک را بر پایه دو تعریف قبلی who و atpiii بیان کرده است. مطالعه حاضر با هدف تعیین شیوع سندرم متابولیک بر اساس این تعاریف و تعیین میزان هم خوانی تعریف idf با معیارهای atpiii و who طراحی شده است. روش ها: مطالعه حاضر یک مطالعه مقطعی است که در آن 10368 مرد و زن بالای 20 ...
full textمقایسه تأثیر وضعیت طاق باز و دمر بر وضعیت تنفسی نوزادان نارس مبتلا به سندرم دیسترس تنفسی حاد تحت درمان با پروتکل Insure
کچ ی هد پ ی ش مز ی هن ه و فد : ساسا د مردنس رد نامرد ي سفنت سرتس ي ظنت نادازون داح ي سکا لدابت م ي و نژ د ي سکا ي د هدوب نبرک تسا طسوت هک کبس اـه ي ناـمرد ي فلتخم ي هلمجزا لکتورپ INSURE ماجنا م ي دوش ا اذل . ي هعلاطم ن فدهاب اقم ي هس عضو ي ت اه ي ندب ي عضو رب رمد و زاب قاط ي سفنت ت ي هـب لاتـبم سراـن نادازون ردنس د م ي سفنت سرتس ي لکتورپ اب نامرد تحت داح INSURE ماجنا درگ ...
full textشیوع سندرم متابولیک در افراد مسن بر اساس سه تعریف ATPIII، IDF و WHO و بررسی ارتباط آن با بیماری‌های کرونری
Background: The aim of this study was to examine the prevalence of the metabolic syndrome (MetS) and its association with coronary heart disease (CHD) in Iranian older individuals. Methods: In this cross-sectional study, the prevalence of the MetS was determined according to the Third Adult Treatment Panel (ATPIII), the World Health Organization (WHO) and the International Diabetes Federation (...
full textشیوع سندرم متابولیک در یک جمعیت شهری: مطالعه قند و لیپید تهران
The aim of the present investigation was to determine the prevalence of metabolic syndrome.Materials and Methods: Metabolic syndrome was defined by the presence of three or more of the following components: abdominal obesity, hypertriglyceridemia, low HDL-C, high blood pressure, and high fasting glucose.Results: In this study, 10368 of the adults (4397 men and 5971 women) aged 20 years and over...
full textتعیین شیوع سندرم متابولیک بین کودکان9-3 ساله در مطالعه قند و لیپید تهران
Background: The metabolic syndrome is a constellation of risk factors that increase the incidence of cardiovascular disease and type 2 diabetes mellitus in adults. Some studies in recent years have found evidence of initiation of this disease in childhood and of the association of childhood obesity with adult cardiovascular disease and diabetes. The present study was carried out to determine th...
full textMy Resources
Journal title
volume 6 issue None
pages 367- 375
publication date 2007-06
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023